Clinicopathological features of bladder cancer associated with chronic exposure to arsenic

British Journal of Cancer

Volumn 75, Issue 11, 1997, Pages 1708-1710

  Chow, N H ^a   Guo, Y L ^a   Lin, J S N ^a   Su, J H J ^a   Tzai, T S ^a   Guo, H R ^a   Su, I J ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Arsenic; Bladder cancer; Carcinogenesis; Pathobiology

Indexed keywords

ARSENIC;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER INCIDENCE; CARCINOGENESIS; CLINICAL FEATURE; FEMALE; HUMAN; LONG TERM EXPOSURE; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PRIORITY JOURNAL;

EID: 0030905288     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.291     Document Type: Article

References (15)

1. Chen CJ and Wang CJ (1990) Ecological correlation between arsenic level in well water and age-adjusted mortality from malignant neoplasms. Cancer Res 50: 5470
2. Chen CJ, Chuang YC, You SL, Lin TM and Wu HY (1986) A retrospective study on malignant neoplasms of bladder, lung, and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 53: 399
3. Chen CJ, Chen CW, Wu MM and Kuo TL (1992) Cancer potential in liver, lung, bladder, and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer 66: 888
4. Chiang HS, Guo HR, Hong CL, Lin SM and Lee EF (1993) The incidence of bladder cancer in the black foot disease endemic area in Taiwan. Br J Urol 71: 274
5. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, Lin SN, Huang CH and Chen CJ (1995) Incidence of internal cancers and ingested inorganic arsenic: A seven-year follow-up study in Taiwan. Cancer Res 55: 1296
6. Cuzick J, Sasieni P and Evans S (1992) Ingested arsenic, keratosis, and bladder cancer. Am J Epidemiol 136: 417
7. Dong JT and Luo XM (1993) Arsenic-induced DNA-strand breaks associated with DNA-protein crosslinks in human fetal lung fibroblasts. Mutat. Res., 302, 97
8. Lee SE, Chow NH, Chi YC, Tzai TS, Yang WH and Lin SN (1994) Expression of c-erbB-2 protein in normal and neoplastic urothelium: Lack of adverse prognostic effect in human urinary bladder cancer. Anticancer Res 14: 1317
9. Lee TC, Wang-Wuu S, Huang RY, Lee KC and Jan KY (1986) Differential effects of pre- and posttreatment of sodium arsenite on the genotoxicity of methyl methanesulfonate in Chinese hamster ovary cells. Cancer Res 46: 1854
10. Rossman TG, Stone M, Molina M and Troll W (1980) Absence of arsenite mutagenicity in Escherichia coli and Chinese hamster cells. Environ Mutagen 2: 371
11. Shibata A, Ohneseit PF, Tsai YC, Spruck CH III, Nichols PW, Chiang HS, Lai MK and Jones PA (1944) Mutational spectrum in the p53 gene in bladder tumors from the endemic area of black foot disease in Taiwan. Carcinogenesis 15: 1085
12. Smith AH, Hopenhayn-Rich C, Bates MN, Goeden HM, Hertz-Picciotto I, Duggan HM, Wood R, Kosnett MJ and Smith MT (1992) Cancer risks from arsenic in drinking water. Environ Health Perspect 97: 259
13. Su IJ, Chen WJ, Huang MH, Lin RS (1985) High frequency of transitional cell carcinoma of the urinary tract in an endemic area of chronic arsenicism in Taiwan. J Chinese Oncol Soc 1: 29
14. Tseng WP (1968) Effects and dose-response relationship of skin cancer and blackfoot disease with arsenic. Environ Health Perspect 19: 109
15. Tsuda T, Babazono A, Yamamoto E, Kurumatani N, Mino Y, Ogawa T, Kishi Y and Aoyama H (1995) Ingested arsenic and internal cancer: A historical cohort study followed for 33 years. Am J Epidemiol 141: 198